INS and Hyperglycemia: Treatment of NOD mice with MSCs attenuated hyperglycemia of early-onset autoimmune diabetes and increased amylin levels, reflective of autoimmune diabetes improvement; reduced the amount of inflammatory cell infiltration, maintaining insulin expression in pancreatic islets by suppressing the Th1 immune response in the pancreas; and promoted the high expression of active TGF-β1 (60).